Proton pump inhibition for secondary hemochromatosis in hereditary anemia, a phase III placebo controlled randomized cross-over clinical trial.

Trial Profile

Proton pump inhibition for secondary hemochromatosis in hereditary anemia, a phase III placebo controlled randomized cross-over clinical trial.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2018

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Anaemia; Beta-thalassaemia; Haemochromatosis; Sideroblastic anaemia
  • Focus Therapeutic Use
  • Acronyms PPI Shine Again
  • Most Recent Events

    • 08 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top